CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides [NA]
Summary
A Chung Shan Medical University study is evaluating blood glucose-regulating effects of Momordica charantia peptides in people with prediabetes; the trial is cu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chung Shan Medical University | Conditions: People With Prediabetic | NA | Status: RECRUITING